Gene Therapy for Inherited Liver Disease: To Add or to Edit
Yue Chen, Niek P van Til, Piter J Bosma, Young Woo Eom · 2024
Read Gene Therapy for Inherited Liver Disease: To Add or to Edit by Yue Chen, Niek P van Til, Piter J Bosma, Young Woo Eom (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640881.txt.
Description
Chen and co-authors published a 2024 review of gene therapy strategies for inherited liver disease: adding a good gene copy, or editing the faulty one. Transplant was long the only cure, at the price of lifelong immune suppression. Gene therapy has now reached the market for hemophilia A and B, and the authors survey what comes next for other liver disorders. Diseases from missing protein function suit gene addition.
Diseases where the mutant protein itself poisons the liver need stronger medicine: integrating vectors or genome editing that change the DNA permanently. The review weighs each strategy's strengths and limits against the disease mechanism. The authors frame the choice as matching the tool to the genetic fault. Progress, they note, is turning one-time treatments into realistic options.
Catalog record
| CREATOR | Yue Chen, Niek P van Til, Piter J Bosma, Young Woo Eom |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |